Amarin Corp Plcuk (AMRN) Current Assets (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Current Assets of $626.0 million for Q1 2026, up 9.24% YoY from $573.1 million in Q1 2025, and down 3.67% sequentially from $649.9 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Current Assets (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Current Assets across 17 years of filings, most recently posting $626.0 million for Q1 2026.

  • In Q1 2026, Current Assets rose 9.24% year-over-year to $626.0 million; the TTM figure through Mar 2026 stood at $626.0 million (up 9.24% YoY), while the FY2025 annual figure was $649.9 million, up 9.15% from the prior year.
  • Current Assets declined to $626.0 million in Q1 2026, from $649.9 million in the prior quarter.
  • Over the last five years, Current Assets for AMRN reached as high as $772.6 million in Q1 2022 and fell as low as $573.1 million in Q1 2025.
  • The 5-year median for Current Assets is $686.5 million (2022), against an average of $671.7 million.
  • Annual changes were most pronounced in 2022 — Current Assets fell 28.71% — and 2026, when it rose 9.24%.
  • A 5-year view of Current Assets shows it stood at $689.1 million in 2022, then increased by 5.21% to $725.0 million in 2023, then declined by 17.87% to $595.4 million in 2024, then grew by 9.15% to $649.9 million in 2025, then retreated by 3.67% to $626.0 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $626.0 million, $649.9 million, and $628.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 54.84 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 59.17 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 33.53 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 29.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 35.02 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 31.48 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 18.64 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 42.82 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 626.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 626.00 Mn
Dec 31, 2025 649.88 Mn
Sep 30, 2025 628.30 Mn
Jun 30, 2025 606.80 Mn
Mar 31, 2025 573.06 Mn
Dec 31, 2024 595.40 Mn
Sep 30, 2024 650.22 Mn
Jun 30, 2024 701.80 Mn
Mar 31, 2024 687.90 Mn
Dec 31, 2023 724.98 Mn
Sep 30, 2023 717.51 Mn
Jun 30, 2023 706.50 Mn
Mar 31, 2023 683.80 Mn
Dec 31, 2022 689.10 Mn
Sep 30, 2022 686.52 Mn
Jun 30, 2022 719.10 Mn
Mar 31, 2022 772.62 Mn
Dec 31, 2021 878.73 Mn
Sep 30, 2021 963.03 Mn
Jun 30, 2021 996.00 Mn